The Second World War in Europe disrupted the supply of cod liver oil, an important source of Vitamin A. Faulding chemists found an alternative source in White Schnapper (or School) Shark, which sustained supplies in Australia as well as generated export to the UK.
When supplies of I.G. Farben's newly discovered sulpha drugs ran out. Faulding become involved in the national program organised by the Medical Equipment Control Committee (MECC) and jointly with universities, synthesised sulphanilamide.
Faulding's was also the first private enterprise to produce yet another life saving drug of military importance, Penicillin. After the war, basic synthesis of antibiotics became difficult to sustain by private enterprise because of the gigantic scale advantages of competing US producers and Faulding's maintained their business by a combination of marketing, wholesaling and producing consumer and medical products.
In 1969 a landmark corporate plan was developed which saw Faulding's in the 70's set a remarkable precedent in research strategy and achievement for an Australian Pharmaceutical business. The company reformulated high technology drugs and decided to market its products internationally. A number of non profitable lines were deleted from production. So, began the release of many drugs we know today. Betadine was launched in 1971, and in 1977 the broad spectrum antibiotic Eryc. In 1984 Faulding acquired David Bull Laboratories and expertise to manufacture injectable anti-cancer drugs.